Essa Pharma Inc News - EPI

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019 Canada...

ESSA Pharma Grants Stock Options

ESSA Pharma Grants Stock Options Canada NewsWire HOUSTON and VANCOUVER, Oct. 30, 2019 HOUSTON and VANCOUVER, Oct. 30, 2019 /CNW/ - ESSA Pharma...

ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeu...

ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Canada...

ESSA Announces Changes to its Board of Directors

ESSA Announces Changes to its Board of Directors Canada NewsWire VANCOUVER and HOUSTON, TX, Oct. 18, 2019 VANCOUVER and HOUSTON, TX, Oct. 18...

ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants

ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants Canada NewsWire VANCOUVER and HOUSTON, Oct. 7, 2019...

ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress

ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress Canada NewsWire HOUSTON and VANCOUVER...

ESSA to Present at Ladenburg Thalmann Healthcare Conference

ESSA to Present at Ladenburg Thalmann Healthcare Conference Canada NewsWire HOUSTON and VANCOUVER, Sept. 19, 2019 HOUSTON and VANCOUVER, Sept...

ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference

ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference Canada NewsWire HOUSTON and VANCOUVER, Sept. 5, 2019 HOUSTON...

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million Canada NewsWire VANCOUVER...

L'OCRCVM permet la reprise de la négociation - EPI

L'OCRCVM permet la reprise de la négociation - EPI Canada NewsWire VANCOUVER, le 23 août 2019 VANCOUVER, le 23 août 2019 /CNW/...

IIROC Trading Resumption - EPI

IIROC Trading Resumption - EPI Canada NewsWire VANCOUVER, Aug. 23, 2019 VANCOUVER, Aug. 23, 2019 /CNW/ - Trading resumes in: Company: ESSA...

Suspension de la négociation par l'OCRCVM - EPI

Suspension de la négociation par l'OCRCVM - EPI Canada NewsWire VANCOUVER, le 23 août 2019 VANCOUVER, le 23 août 2019 /CNW/ - L'OCRCVM...

IIROC Trading Halt - EPI

IIROC Trading Halt - EPI Canada NewsWire VANCOUVER, Aug. 23, 2019 VANCOUVER, Aug. 23, 2019 /CNW/ - The following issues have been halted by...

ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement

ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement Canada NewsWire VANCOUVER and HOUSTON, Aug...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019 Canada NewsWire VANCOUVER and...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Essa Pharma Inc (EPI)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

EPI News

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma Grants Stock Options

ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeu...

ESSA Announces Changes to its Board of Directors

ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants

ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress

ESSA to Present at Ladenburg Thalmann Healthcare Conference

ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

L'OCRCVM permet la reprise de la négociation - EPI

IIROC Trading Resumption - EPI

Suspension de la négociation par l'OCRCVM - EPI

IIROC Trading Halt - EPI

ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019

EPI Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Essa Pharma Inc (EPI) News

Essa Pharma Inc (EPI)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

EPI News

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma Grants Stock Options

ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeu...

ESSA Announces Changes to its Board of Directors

ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants

ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress

ESSA to Present at Ladenburg Thalmann Healthcare Conference

ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

L'OCRCVM permet la reprise de la négociation - EPI

IIROC Trading Resumption - EPI

Suspension de la négociation par l'OCRCVM - EPI

IIROC Trading Halt - EPI

ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019

EPI Discussion

Your Recent History